RedHill Biopharma(RDHL) - Prospectus

As filed with the Securities and Exchange Commission on February 9, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REDHILL BIOPHARMA LTD. (Exact name of registrant as specified in its charter) Israel (State or other jurisdiction of incorporation or organization) RedHill Biopharma Inc. 8045 Arco Corporate Drive, Suite 200 Raleigh, NC 27617 (984) 444-7010 (Name, address, including zip code, and ...